Alberto Bergamini - Concepedia

Author

Alberto Bergamini

Also Known As

A BERGAMINI, A Bergamini, A. BERGAMINI, A. Bergamini, A;Thomas M. Bergamini, ALBERTO BERGAMINI, Alberto BERGAMINI, Alberto Bergamini, Alberto Bergamini,, Alessia Bergamini

159

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Rome Tor Vergata Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani University of Siena Istituto di Genetica Molecolare Sapienza University of Rome

About

Alberto Bergamini is an author at University of Rome Tor Vergata specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	26	1.2K
2	Natural Sciences	4	4	323
3	Engineering	3	3	82
4	Education	1	1	24
5	Allergy	1	1	28

Alberto Bergamini

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
1α,25-Dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in Human Monocytes C. Almerighi, Anna Sinistro, Antonella Cavazza, Cytokine InflammationCytokineAnti-inflammatoryHuman MonocytesMedicine	2009	216
Design, Molecular Modeling, Synthesis, and Anti-HIV-1 Activity of New Indolyl Aryl Sulfones. Novel Derivatives of the Indole-2-carboxamide Rino Ragno, Antonio Coluccia, Giuseppe La Regina, Journal of Medicinal Chemistry Bioorganic ChemistryHiv-ab1 Primary IsolatesOrganic ChemistryChemistryAntiviral Drug	2006	180
Increased hepatitis C virus (HCV)-specific CD4+CD25 + regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal<i>versus</i>abnormal alanine aminotransferase levels Francesca Bolacchi, Anna Sinistro, Chiara Ciaprini, Clinical & Experimental Immunology Hepatitis C VirusT-regulatory CellImmunologyPathologyCd4 T Cell Responses	2006	142
Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent Giuseppe Campiani, Francesca Aiello, Monica Fabbrini, Journal of Medicinal Chemistry Oral BioavailabilityAntiviral DrugChemical BiologyMedicinal ChemistryAntiviral Drug Development	2001	94
Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options Silvia Natoli, Carla Fontana, Marco Favaro, BMC Infectious Diseases	2009	90
Proinflammatory Modulation of the Surface and Cytokine Phenotype of Monocytes in Patients With Acute Charcot Foot Luigi Uccioli, Anna Sinistro, C. Almerighi, Diabetes Care	2009	86
Human Kupffer Cell Recognition and Phagocytosis of Apoptotic Peripheral Blood Lymphocytes Laura Falasca, Alberto Bergamini, Annalucia Serafino, Experimental Cell Research InflammationGranulocyteApoptosisImmunologyHematology	1996	79
Clinical analysis of human urine by means of potentiometric Electronic tongue Larisa Lvova, Eugenio Martinelli, F. Dini, Talanta Human UrinePotentiometric Electronic TongueElectronic TongueUrologyUrological Research	2008	63
Indolyl Aryl Sulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Role of Two Halogen Atoms at the Indole Ring in Developing New Analogues with Improved Antiviral Activity Giuseppe La Regina, Antonio Coluccia, Francesco Piscitelli, Journal of Medicinal Chemistry	2007	59
Novel 1-[2-(Diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. A Structure−Activity Relationship Investigation Gabriella Martino, Giuseppe La Regina, Alessandra Pasquali, Journal of Medicinal Chemistry	2005	55

Page 1